BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20010439)

  • 1. Cytochalasin D, LY294002 and olomoucine synergize in promoting death of melanoma cells through activation of caspase-3 and apoptosis.
    Małecki JM; Bentke A; Ostrowska B; Laidler P
    Melanoma Res; 2010 Feb; 20(1):52-8. PubMed ID: 20010439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy inhibitors chloroquine and LY294002 enhance temozolomide cytotoxicity on cutaneous melanoma cell lines in vitro.
    Ryabaya OO; Inshakov AN; Egorova AV; Emelyanova MA; Nasedkina TV; Zasedatelev AS; Khochenkov DA; Stepanova EV
    Anticancer Drugs; 2017 Mar; 28(3):307-315. PubMed ID: 27941537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tanespimycin and tipifarnib exhibit synergism in inducing apoptosis in melanoma cell lines from later stages of tumor progression.
    Bentke A; Małecki J; Ostrowska B; Krzykowska-Petitjean K; Laidler P
    Cancer Invest; 2013 Oct; 31(8):545-9. PubMed ID: 24066674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cdk inhibitors, roscovitine and olomoucine, synergize with farnesyltransferase inhibitor (FTI) to induce efficient apoptosis of human cancer cell lines.
    Edamatsu H; Gau CL; Nemoto T; Guo L; Tamanoi F
    Oncogene; 2000 Jun; 19(27):3059-68. PubMed ID: 10871858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic augmentation of antimicrotubule agent-induced cytotoxicity by a phosphoinositide 3-kinase inhibitor in human malignant glioma cells.
    Shingu T; Yamada K; Hara N; Moritake K; Osago H; Terashima M; Uemura T; Yamasaki T; Tsuchiya M
    Cancer Res; 2003 Jul; 63(14):4044-7. PubMed ID: 12874004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of phosphatidylinositol 3'-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.
    Hu L; Hofmann J; Lu Y; Mills GB; Jaffe RB
    Cancer Res; 2002 Feb; 62(4):1087-92. PubMed ID: 11861387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockage of cyclin cdk's, PKC and phosphoinositol 3-kinase pathways leads to augmentation of apoptosis in drug-resistant leukemia cells: evidence for interactive effects of flavopiridol, LY 294002, roscovitine,wortmannin and UCN-01.
    Cory AH; Somerville L; Cory JG
    Anticancer Res; 2005; 25(1A):101-6. PubMed ID: 15816525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased caspase-2 activity is associated with induction of apoptosis in IFN-beta sensitive melanoma cell lines.
    Kamiya T; Okabayashi T; Yokota S; Kan Y; Ogino J; Yamashita T; Fujii N; Jimbow K
    J Interferon Cytokine Res; 2010 May; 30(5):349-57. PubMed ID: 20187765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potential role for resveratrol as a radiation sensitizer for melanoma treatment.
    Fang Y; Bradley MJ; Cook KM; Herrick EJ; Nicholl MB
    J Surg Res; 2013 Aug; 183(2):645-53. PubMed ID: 23522452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis induction of human leukemia cells by Streptomyces sp. SY-103 metabolites through activation of caspase-3 and inactivation of Akt.
    Jeong SY; Han MH; Jin CY; Kim GY; Choi BT; Nam TJ; Kim SK; Choi YH
    Int J Mol Med; 2010 Jan; 25(1):31-40. PubMed ID: 19956899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parthenolide, a sesquiterpene lactone from the medical herb feverfew, shows anticancer activity against human melanoma cells in vitro.
    Lesiak K; Koprowska K; Zalesna I; Nejc D; Düchler M; Czyz M
    Melanoma Res; 2010 Feb; 20(1):21-34. PubMed ID: 19949351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A three-drug nanoscale drug delivery system designed for preferential lymphatic uptake for the treatment of metastatic melanoma.
    Doddapaneni BS; Kyryachenko S; Chagani SE; Alany RG; Rao DA; Indra AK; Alani AWG
    J Control Release; 2015 Dec; 220(Pt A):503-514. PubMed ID: 26578440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53.
    Bush JA; Cheung KJ; Li G
    Exp Cell Res; 2001 Dec; 271(2):305-14. PubMed ID: 11716543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells.
    Petrucci E; Pasquini L; Petronelli A; Saulle E; Mariani G; Riccioni R; Biffoni M; Ferretti G; Benedetti-Panici P; Cognetti F; Scambia G; Humphreys R; Peschle C; Testa U
    Gynecol Oncol; 2007 May; 105(2):481-92. PubMed ID: 17292950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic interaction between 17-AAG and phosphatidylinositol 3-kinase inhibition in human malignant glioma cells.
    Premkumar DR; Arnold B; Jane EP; Pollack IF
    Mol Carcinog; 2006 Jan; 45(1):47-59. PubMed ID: 16267832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The attenuating effect of memantine on staurosporine-, salsolinol- and doxorubicin-induced apoptosis in human neuroblastoma SH-SY5Y cells.
    Jantas D; Pytel M; Mozrzymas JW; Leskiewicz M; Regulska M; Antkiewicz-Michaluk L; Lason W
    Neurochem Int; 2008; 52(4-5):864-77. PubMed ID: 17996985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gambogic acid induces apoptosis by regulating the expression of Bax and Bcl-2 and enhancing caspase-3 activity in human malignant melanoma A375 cells.
    Xu X; Liu Y; Wang L; He J; Zhang H; Chen X; Li Y; Yang J; Tao J
    Int J Dermatol; 2009 Feb; 48(2):186-92. PubMed ID: 19200201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)-mediated signaling pathway.
    Nguyen DM; Chen GA; Reddy R; Tsai W; Schrump WD; Cole G; Schrump DS
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):365-75. PubMed ID: 14762343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetaminophen potentiates staurosporine-induced death in a human neuroblastoma cell line.
    Posadas I; Vellecco V; Santos P; Prieto-Lloret J; Ceña V
    Br J Pharmacol; 2007 Mar; 150(5):577-85. PubMed ID: 17245372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination regimen of idarubicin and taxotere is effective against human drug-resistant leukemic cell lines.
    Majlessipour F; Avramis IA; Kwock R; Weinberg KI; Avrami VI
    Anticancer Res; 2002; 22(3):1361-8. PubMed ID: 12168812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.